Shopping Cart
Remove All
Your shopping cart is currently empty
Lutikizumab (Synonyms: ABT-981)
Catalog No. T77077 Copy Product Info
🥰Excellent
Lutikizumab is a bispecific antibody against IL-1α and IL-1β with a bivalent variable domain structure. By binding to IL-1α and IL-1β, Lutikizumab effectively inhibits their activity and is mainly used in the field of osteoarthritis research.
Lutikizumab
Copy Product Info🥰Excellent
Catalog No. T77077
Synonyms ABT-981
Lutikizumab is a bispecific antibody against IL-1α and IL-1β with a bivalent variable domain structure. By binding to IL-1α and IL-1β, Lutikizumab effectively inhibits their activity and is mainly used in the field of osteoarthritis research.
Cas No. 1791411-57-8
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $456 | - | In Stock | |
| 5 mg | $1,160 | - | In Stock | |
| 10 mg | $1,850 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:>95% (SDS-PAGE); 99.63% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Lutikizumab is a bispecific antibody against IL-1α and IL-1β with a bivalent variable domain structure. By binding to IL-1α and IL-1β, Lutikizumab effectively inhibits their activity and is mainly used in the field of osteoarthritis research. |
| In vitro | Lutikizumab binds specifically to both human IL‑1α and IL‑1β proteins.Compared with other cytokines in the IL‑1 family, lutikizumab exhibits highly specific binding to both IL‑1α and IL‑1β [1]. |
| In vivo | Lutikizumab significantly inhibits IL‑6 production induced by IL‑1α and IL‑1β following a single intraperitoneal injection at doses of 0.0001–1 mg/kg [1]. |
| Synonyms | ABT-981 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal, Bispecific |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-1α/IL-1β |
| Molecular Weight | 196.82 kDa |
| Cas No. | 1791411-57-8 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
Preview
Related Tags: buy Lutikizumab | purchase Lutikizumab | Lutikizumab cost | order Lutikizumab | Lutikizumab chemical structure | Lutikizumab in vivo | Lutikizumab in vitro | Lutikizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.